GGrantIndex
Sort

39,280 grants matching leukemia

Attacking anthrax action by blocking receptor signaling

$342,000
Dana-Farber Cancer Institute · R21 · FY2004 · AI

P1: Epigenetic Staging and Therapy for Lung Cancers

$341,984
James G. Herman · Johns Hopkins University · P50 · FY2012 · CA

Posttranscriptional Regulation of Oncogene Messenger RNA

$341,980
Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2004 · CA

Architectural Basis of Leptin Transmembrane Signaling

$341,962
Georgios Skiniotis · University Of Michigan At Ann Arbor · R01 · FY2014 · DK

Signaling Pathway in Ah Receptor-Dependent Control of Hematopoietic Stem Cells

$341,921
Thomas A Gasiewicz · University Of Rochester · R01 · FY2014 · ES

Bone Pseudoarthrosis Dissected through the Generation of New Mouse Models

$341,921
Florent Elefteriou · Vanderbilt University · R01 · FY2010 · AR

Function and Biology of Eukaryotic DNA Topoisomerases

$341,921
Neil Osheroff · Vanderbilt University · R01 · FY2010 · GM

BIOCHEMISTRY OF LEUKEMIA VIRUS CORE BINDING FACTOR

$341,909
Dartmouth College · R01 · FY2000 · CA

Mechanisms of Pbx-directed Genetic & Transcriptional Control of Limb Development

$341,907
Licia Selleri · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · HD

Shared Resource 08: Genomics (GSR)

$341,893
Amanda Ewart Toland · Ohio State University · P30 · FY2025 · CA

Th1/Th17 Cell Differentiation in GVHD and GVL

$341,867
Xue-Zhong Yu · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2012 · CA

A Leukemia Cell-Specific Coiled-Coil Protein for Treatment of Chronic Myeloid Leukemia

$341,867
Carol S Lim · University Of Utah · R01 · FY2023 · CA

Drug-Free Macromolecular Therapeutics

$341,867
Jindrich N. Kopecek · University Of Utah · R01 · FY2022 · CA

A Leukemia Cell-Specific Coiled-Coil Protein for Treatment of Chronic Myeloid Leukemia

$341,867
Carol S Lim · University Of Utah · R01 · FY2022 · CA

Gene Therapy for Human Malignant Melanoma

$341,818
Introgen Therapeutics, Inc. · R42 · FY2003 · CA

Development of Liposome Complexed RNA Quality Controls

$341,814
Maine Molecular Quality Controls, Inc. · R44 · FY2003 · GM

Architectural Basis of Leptin Transmembrane Signaling

$341,772
Georgios Skiniotis · University Of Michigan At Ann Arbor · R01 · FY2015 · DK

Regulation of the tumor suppressor PTEN

$341,760
Burnham Institute For Medical Research · R01 · FY2003 · CA

Regulation of TAL1/SCL in T-Cell Leukemia

$341,753
Suming Huang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2018 · CA

GENETIC ANALYSIS OF GENES CONTROLLING A POSITION EFFECT

$341,743
University Of California Berkeley · R37 · FY2003 · GM

MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM

$341,738
Rogerio C. Lilenbaum · Mount Sinai Medical Center (Miami Beach) · U10 · FY2009 · CA

The Osteoblast as a Determinant of Leukemogenesis

$341,711
Stavroula Kousteni · Columbia University Health Sciences · R01 · FY2017 · AR

The Osteoblast as a Determinant of Leukemogenesis

$341,711
Stavroula Kousteni · Columbia University Health Sciences · R01 · FY2016 · AR

The Osteoblast as a Determinant of Leukemogenesis

$341,711
Stavroula Kousteni · Columbia University Health Sciences · R01 · FY2015 · AR

Improving BTK Directed Therapy for CLL

$341,706
Jennifer A. Woyach · Ohio State University · R01 · FY2019 · CA